Task: Answer the multiple-choice question.
Question: Which compound exhibits a -29.823% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
[a] O=C(c1csc2c1CCCC2)N1CCN(c2cccc(C(F)(F)F)c2)CC1
[b] O=c1[nH]c(=S)n(C2CCCCC2)c(O)c1/C=N/N1CCOCC1
[c] CC(C)C[C@]1(c2ccccc2)ON(c2ccccc2C(F)(F)F)C1=O
Answer: b. O=c1[nH]c(=S)n(C2CCCCC2)c(O)c1/C=N/N1CCOCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=c1[nH]c(=S)n(C2CCCCC2)c(O)c1/C=N/N1CCOCC1
O=c1[nH]c(=S)n(C2CCCCC2)c(O)c1/C=N/N1CCOCC1
1-cyclohexyl-6-hydroxy-5-[(E)-morpholin-4-yliminomethyl]-2-sulfanylidenepyrimidin-4-one